: Neogen receives FDA approval for Salmonella test Neogen announced that its rapid test for Salmonella enteritidis has been determined by the U.S. Food and Drug Administration to be equivalent to the FDA's traditional testing method in accuracy, precision, and sensitivity for detecting SE. The FDA's determination of equivalency will allow egg producers and processors to use Neogen's Reveal for SE to shorten the testing time and comply with the FDA's recently implemented SE-regulations without further scrutiny. In November, the AOAC International validated the accuracy of the Reveal for SE system when testing either environmental or egg samples.
Yes, the FDA released a report this morning with the approvals for each company. It appears that both meet the eqivalent FDA benchmark, but only SDIX can do certain SE tests without a 96 hour wait period. This distinction is intereting and could be of interest to a larger company that has better marketing and distribution to go head to head with NEOG.